Global Salivary Gland Infection Market is expected to reach USD 12,264.3 Million by 2030

Pune, India, July, 11 2022 /MRFR Press Release/- Market research future has a half cooked research report on global salivary gland infection market. The Global Salivary Gland Infection Market is growing continuously and expected to grow at a CAGR of 9.3% from 2022 to 2030

Taste the market data and market information presented through more than 61 market data tables and figures spread over 76 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Salivary Gland Infection Market Research Report –Global Forecast to 2030.”

Salivary Gland Infection Market Highlights

The Salivary Gland Infection Market is expected to reach USD 12,264.3 Million by 2030 at 9.3% CAGR during the forecast period 2022-2030

The global salivary gland infection market has been evaluated as a moderately growing market and it is expected to continue growing in the near future. Increasing prevalence of salivary gland infections are major driver for the market growth. Some other factors such as changing disease patterns, smoking, and changing environment are driving the growth of global salivary gland infection market.

Major players in Salivary Gland Infection market:

There are plenty of large and small market players which operate in this market: AbbVie Inc. (US), Allergan (Republic of Ireland), AstraZeneca (UK), FUJIFILM Holdings Corporation (Japan), General Electric Company (US), GlaxoSmithKline plc. (UK), Johnson & Johnson Services, Inc. (US), Merck & Co., Inc. (US), Pfizer Inc.(US), Siemens Healthcare GmbH (Germany), and others.

Key players of this market are focusing on the development of advanced medical imaging devices for effective diagnosis of disease or disorder. Drug manufactures are investing large amount of money in new product development as well as improvement of existing product to derive efficient solution for market. Competition among the major and small players is very intense. Top players are holding majority of market share while medium and small companies are also holding small but major piece of this market.

WOCKHARDT’s a global pharmaceutical and biotechnology organization is under clinical development of its Second-generation Ketolide drug which can treat serious bacterial infections.

Segmentation:

Global salivary gland infection market has been segmented on the basis of diagnosis which comprises of Plain radiography, sialography, high-resolution ultrasonography, Computed tomography (CT), Magnetic resonance imaging (MRI), radionuclide scintigraphy, and others. Sialography is further sub-segmented into CT sialography (ultrafast technique), fluoroscopic/conventional sialography (with or without digital subtraction), and MR sialography.

On the basis of treatment, the market has been segmented into medication, surgery, aspiration, home care, and others. Medication is further sub-segmented into antibiotics and others. Antibiotics are further sub-segmented into dicloxacillin, cephalosporins, clindamycin, and others. Surgery includes removal of part of the parotid salivary gland, removal of all of the parotid salivary gland, removal of the submandibular salivary gland, and others. Home remedies includes increased water intake, rest, refraining from smoking, massaging the gland with heat, and others.

On the basis of end user, it is segmented into hospitals & clinics, medical research centers, academic institutes, and others.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Salivary Gland Infection Market Research Report

Regional Analysis:

Considering the global scenario of the salivary gland infection market, in 2016, Americas was holding the largest market share in global salivary gland infection. US is dominating and top revenue generator in Americas market that is mainly due to some factors like increasing investment research and clinical trials. European market is the second largest market for salivary gland infection. Increasing prevalence and growing knowledge of disease are major driving forces for the growth of Asia Pacific salivary gland infection market. Middle East and Africa salivary gland infection market is expected to limited growth it is mostly because of limited availability products, access to the healthcare, lack of knowledge of diseases and treatment, traditional healthcare practices etc.